Trichostatin A Ms275
Trichostatin A Ms275 - Related Videos
09:20
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
0 Views •
Cited by 6 •
2017
The present method serves to identify isoform-specific inhibitors of histone deacetylases (HDAC) in HeLa cells by the UHPLC-MS analysis of multiple substrates. This is an antibody-free method developed to reflect HDAC1 and HDAC6 activity in the living cell environment, in contrast to single-isoform cell-free assays.
09:52
Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer
0 Views •
Cited by 20 •
2018
We describe a dramatically improved method for mouse cloning using trichostatin A, vitamin C, and deionized bovine serum albumin. We show a simplified, reproducible protocol that supports efficient development of cloned embryos. Hence, this method could become a standardized procedure for mouse cloning.
09:28
A Microfluidic Device for Quantifying Bacterial Chemotaxis in Stable Concentration Gradients
0 Views •
Cited by 7 •
2010
This protocol describes the development of a microfluidic device for investigating bacterial chemotaxis in stable concentration gradients of chemoeffectors.
07:34
Manipulation of Rhythmic Food Intake in Mice Using a Custom-Made Feeding System
0 Views •
2022
Restricting the timing of food intake has emerged as a promising intervention to attenuate diet-induced metabolic diseases. This manuscript details the construction and use of an efficient system built in-house for measuring and manipulating rhythmic food intake in mice.
15:06
Synthesis of an Intein-mediated Artificial Protein Hydrogel
0 Views •
Cited by 2 •
2014
We present the synthesis of a split-intein-mediated protein hydrogel. The building blocks of this hydrogel are two protein copolymers each containing a subunit of a trimeric protein that serves as a crosslinker and one half of a split intein. Mixing of the two protein copolymers triggers an intein trans-splicing reaction, yielding a polypeptide unit that self-assembles into a hydrogel. This hydrogel is highly pH- and temperature-stable, compatible with organic solvents, and easily incorporates...
FAQs
Their inhibitory mechanisms reflect different chemical structures. Trichostatin A contains a hydroxamic acid that chelates the catalytic Zn2+ ion in HDAC active sites. MS-275, also called entinostat, uses a benzamide structure and inhibits selected class I HDACs. Comparing them helps separate effects associated with zinc-dependent inhibition from those associated with class I selectivity.
Selectivity determines which HDAC-dependent processes are affected most directly. MS-275 targets selected class I HDACs, whereas Trichostatin A is distinguished by its hydroxamic-acid-mediated interaction with HDAC catalytic sites. Using both compounds can therefore reveal whether a change in protein acetylation, transcription, or differentiation reflects broad HDAC inhibition or a more restricted class I response.
Increased acetylation provides a way to examine how reversible protein modification relates to chromatin structure and gene expression. When deacetylation is inhibited, researchers can observe consequences for histones and other proteins rather than examining transcription in an unchanged acetylation state. These observations connect molecular acetylation changes with transcriptional control and cell differentiation.
Reversible acetylation allows researchers to study regulation as a dynamic process rather than as a permanent chemical alteration. HDAC inhibition shifts the balance toward acetylated histones and other proteins, making it possible to investigate how changing that balance influences gene expression and cellular behavior. This is especially useful for linking chemical intervention with regulatory outcomes.
A comparative study can treat the compounds as mechanistically distinct probes and examine how each affects protein acetylation, transcriptional control, or differentiation. The resulting differences help relate biological outcomes to hydroxamic-acid zinc chelation versus benzamide-based inhibition of selected class I HDACs. Such comparisons support interpretation of chemical structure, selectivity, and epigenetic response together.
These compounds support investigations of chromatin structure, gene-expression regulation, cell differentiation, and cancer biology. In epigenetic drug discovery, their differing chemical mechanisms and selectivity provide a framework for evaluating how HDAC inhibition changes acetylation-dependent processes. Their use can also clarify whether observed effects involve histones, other proteins, or broader transcriptional regulation.